• Explore /
  • Poster
  • / Randomized phase III trial of gemcitabine and cisplatin versus gemcitabine alone in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) 2: CAPPA-2 study.

Randomized phase III trial of gemcitabine and cisplatin versus gemcitabine alone in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) 2: CAPPA-2 study.

Abstract Poster

Authors

null

Alessandro Morabito

National Cancer Institute, G.Pascale Foundation, Napoli, Italy

Alessandro Morabito , Vittorio Gebbia , Saverio Cinieri , Maria Grazia Viganò , Roberto Bianco , Santi Barbera , Luigi Cavanna , Filippo De Marinis , Vincenzo Montesarchio , Raffaele Costanzo , Claudia Sandomenico , Agnese Montanino , Gianfranco Mancuso , Angelo Nacci , Pasqualina Giordano , Gennaro Daniele , Cesare Gridelli , Gaetano Rocco , Ciro Gallo , Massimo Di Maio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT00526643

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8066)

DOI

10.1200/jco.2013.31.15_suppl.8066

Abstract #

8066

Poster Bd #

35F

Abstract Disclosures

Similar Posters

First Author: Xinan Sheng

First Author: Zhen-gang Yuan

First Author: Guillermo de Velasco

First Author: Jennifer J. Knox